Chronic Obstructive Pulmonary Disease | End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)
Chronic Obstructive Pulmonary Disease research study
What is the primary objective of this study?
The aim of the study is to develop an interview to ask patients with COPD about their fear of death and dying, their needs and wishes at the end-of-life. Afterwards, the patients receive a brief psychological intervention to develop coping strategies for chronic illness. Beside this a general purpose of this intervention is to improve patients' quality of life.
Who is eligible to participate?
Inclusion Criteria: - 50 years or older - COPD diagnosis III and IV by GOLD-criteria with or without an indication for long-term oxygen therapy (LTOT), non invasive ventilation (NIV) and/or lung transplantation (LTx) - COPD diagnosis II by GOLD-criteria - Patients with hip prosthesis - Mental healthy people, who have no severe illness (such as heart disease or cancer) one year before Exclusion Criteria: - Participation in other studies likely to influence the patient in terms of confounding effects - Acute and severe exacerbations with hard symptoms over 4 days - Patients need a increasing medication of steroids and/or antibiotics - Non-compliance
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Chronic Obstructive Pulmonary Disease
Fear About Death and Dying
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Behavioral:A brief psycho-educational interventionA brief (3 single sessions) psycho-educational program with cognitive-behavioral and disease self-management techniques. This study is an open pilot study ("feasibility study") to develop a palliative psychological program for end-of-life fears in COPD, therefore all participants will be given the opportunity to receive treatment.
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
COPD by GOLD-criteria III and IV
Start Date: October 2008
Completed Date: July 2010
Primary Outcome: Self-reported semi-structured interview about the fear of death and dying, needs and wishes at the end-of-life in patients with severe COPD
Secondary Outcome: St. George's Respiratory Questionnaire (SGRQ)
Study sponsors, principal investigator, and references
Principal Investigator: Winfried Rief, Prof. Dr.
Lead Sponsor: Philipps University Marburg Medical Center